GlaxoSmithKline’s Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease September 28, 2020 Auto Bot News 0 GlaxoSmithKline’s Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease kblankenship Mon, 09/28/2020 – 09:01
